Publication | Closed Access

Reversible and irreversible acetylcholinesterase inhibitors cause changes in neuronal amyloid precursor protein processing and protein kinase C level in vitro

Neurodegenerative DiseasesIrreversible Acetylcholinesterase InhibitorsAlzheimer's DiseaseBiochemistryDegenerative PathologyNeurochemical BiomarkersProtein MisfoldingNeurologyNeuroscienceMolecular NeurobiologyNeuropathologyMedicine